Relationship between baseline health-related quality of life (HRQoL) measures and clinical outcomes of nivolumab (NIVO) or nivolumab plus ipilimumab (NIVO plus IPI) in patients (pts) with unresectable or metastatic melanoma using real-world data from the non-interventional study (NIS) NICO in Germany

Gutzmer, R. and Ugurel, S. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Herbst, R. and Kaehler, K. C. and Kreuter, A. and Meier, F. and Pfoehler, C. and Sachse, M. M. and Herber, M. and Terheyden, P. and Ulrich, J. and Utikal, J. S. and von Wasielewski, I. and Schadendorf, D. (2023) Relationship between baseline health-related quality of life (HRQoL) measures and clinical outcomes of nivolumab (NIVO) or nivolumab plus ipilimumab (NIVO plus IPI) in patients (pts) with unresectable or metastatic melanoma using real-world data from the non-interventional study (NIS) NICO in Germany. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 21. pp. 6-8. ISSN 1610-0379, 1610-0387

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 May 2024 09:33
Last Modified: 14 May 2024 09:33
URI: https://pred.uni-regensburg.de/id/eprint/60625

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.